Effects of growth hormone on assisted pregnancy outcomes in IVF/ICSI patients with poor outcomes

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022473

Enrollment

Unknown

Registered

2019-04-12

Start date

2019-04-11

Completion date

Unknown

Last updated

2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

single arm:growth hormone

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients with IVF/ICSI assisted pregnancies who had no transferred embryos or no high-quality embryos or whose proportion of high-quality embryos was less than 20%.

Exclusion criteria

Exclusion criteria: 1. Severe uterine deformity; 2.Severe uterine adhesion;3. Moderate to severe endometriosis.

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy rate;	—

Secondary

Measure	Time frame
Optimal rate of embryo;	—

Countries

China

Contacts

Public ContactZhou Hanying

Northwest Women's and Children's Hospital

14635652@qq.com+86 15398093292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026